Who is sponsoring NCT07503574?

NCT07503574 is sponsored by Ankara University.

What drugs are being tested in NCT07503574?

Interventions in NCT07503574: % 10 dextrose Hydrodissection, Lidocaine-Saline Hydrodissection.

What condition does NCT07503574 study?

NCT07503574 studies Myofascial Pain Syndrome, Trigger Point Pain, Myofascial, Neck Pain.

Is NCT07503574 still recruiting?

NCT07503574 is currently completed. Last updated 31 March 2026.

Last reviewed 2026-03-31 · How we verify

NCT07503574

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Of The Efficacy Of Interfascial Hydrodissection With A Mixture Of Lidocaine And Physiological Saline Solution With 10% Dextrose In Patients With Chronic Neck Pain

Completed NA Last updated 31 March 2026

What this trial tests

NA trial testing % 10 dextrose Hydrodissection in Myofascial Pain Syndrome in 96 participants. Completed in 15 August 2025.

Timeline

30 April 2025

Primary endpoint
30 July 2025

15 August 2025

Quick facts

Lead sponsor	Ankara University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	96
Start date	30 April 2025
Primary completion	30 July 2025
Estimated completion	15 August 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

% 10 dextrose Hydrodissection
Lidocaine-Saline Hydrodissection

Conditions studied

Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →
Neck Pain — all drugs for Neck Pain →

Sponsor

Ankara University

Who can join

Adults 18 to 65, any sex, with Myofascial Pain Syndrome or Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: This study aimed to investigate the effects of fascial hydrodissection with 10% dextrose or lidocaine-saline on pain, neck functions, and quality of daily life in patients with chronic neck pain due to resistant myofascial trigger points in the upper trapezius muscle unresponsive to conservative treatments, and to determine whether one solution is superior to the other. Materials and Methods: This study is designed as prospective, comparative clinical study. The first group will be applied interfascial hydrodissection with 10% dextrose, and the second group with lidocaine-saline. All participants will be instructed in self-massage and stretching exercises to perform at home to support treatment efficacy. Interventions will be performed under ultrasound guidance, targeting the specified interfascial plane. Evaluations will be conducted at baseline, at 10 minutes post-treatment (VAS, ROM), and at 1-month and 3-month follow-ups (VAS, ROM, NDI, SF-12). Data will be statistically analyzied by comparing pre- and post-treatment measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myofascial Pain Syndrome

Currently open trials in the same condition.

NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07503574 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 31 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07503574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing